25 Aug 2025 argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG Multiple categories
21 Aug 2025 Ardena and MAXONA Pharmaceuticals announce collaboration for development of MAX-001 program Multiple categories
23 Jul 2025 KU Leuven researchers identify promising drug for treating severe malaria Multiple categories
01 Jul 2025 Animab Secures EUR 10 Million in Series B Financing to Launch Nanoprotec® in Europe and Expand Pipeline Multiple categories
30 Jun 2025 argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes Multiple categories
20 Jun 2025 argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
